• SIOPEN2020

    22–23 October 2020 Online

    Annual General Meeting

  • SIOPEN2020

    22–23 October 2020 Online

    Annual General Meeting

Welcome

Welcome

- October 2020, Online

Dear SIOPEN family, friends and colleagues

We would like to invite you to the next SIOPEN Annual General Meeting which will be held Online on October 22st to 23rd, 2020.

We live exciting times in the field of neuroblastoma research in Europe, and the meeting will be a great opportunity to work on future and ongoing clinical trials and projects, enjoy enhanced interaction with clinicians and scientists working in the field in Europe, engage new young investigators, discuss the future strategy of our association and hopefully.

We feel confident that you will leave the meeting with a renewed sense of energy, inspiration, and focus on your work in the field of neuroblastoma.

We look forward to meeting you.

Yours sincerely

Lucas Moreno, Maia Beck-Popovic and Miquel Segura on behalf of SIOPEN and the Organising Committe




Speakers & Organising Committee

Organising Committee




Chair: Lucas Moreno
Clinical Director, Paediatric Haematology & Oncology, Vall d’Hebron Hospital, Barcelona. Member of SIOPEN Drug Development Group, PI of BEACON-Neuroblastoma trial.


Co-Chair: Miquel Segura
Lead of Neuroblastoma lab, Vall d’Hebron Research Institute. Member of SIOPEN Drug Development & Biology Groups.


Adela Cañete
Head of Unit, Paediatric Haematology & Oncology, Hospital La Fe, Valencia. Co-chair of Spanish Neuroblastoma group, PI of LINES trial, member of SIOPEN Drug Devleopment Grou


Ana Fernández-Teijeiro Álvarez
Head of Unit, Paediatric Haematology & Oncology, Hospital Virgen Macarena, Seville. President of SEHOP, Spanish Society of Paediatric Haematology & Oncology.


Lieve Tytgat
Lead of the Tytgat Group, Princess Maxima Centre for Paediatric Oncology, Utrecht, The Netherlands. Lead of the Dutch Neuroblastoma Group and member of SIOPEN Biology group.


Juliet Gray
Associate Professor in Paediatric Oncology, University of Southampton, Lead of Paediatric Oncology and Haematology department, Southampton NHS Foundation Trust, Southampton, UK. Member of SIOPEN Drug development and Immunotherapy groups, PI of the MINIVAN trial.




Maja Beck Popovic
Head of Unit, Paediatric Haematology & Oncology. Centre hospitalier universitaire vaudois Lausanne, Switzerland and Pediatric Surgery

Speakers



  • will be available soon

    will be available soon

Schedule

PROGRAM

October 22th


Opening

Maja Beck Popovic.

Ongoing trials (part 1)
Moderator: Maja Beck Popovic
LINES: Adela Cañete
OMS: Gudrun Schleiermacher
SCI: Shifra Ash

Ongoing trials (part 2)
Moderator: Ruth Ladenstein
VERITAS: Dominique Valteau-Couanet & Mark Gaze
HRNBL2: Dominique Valteau-Couanet
HRNBL2 amendment: Lorlatinib Pablo Berlanga

COG Update

Rochelle Bagatell

Biobreak


Ongoing trials/projects (part 3)
Moderator: Angelika Eggert
BEACON: Lucas Moreno
RIST: Selim Corbacioglu
Relapse guidelines, questionnaires: Angelika Eggert
Surgical results: Sabine Sarnacki
Minivan: Juliet Gray

New projects
Pilot studies: Holger Lode
Bioportal: Gudrun Schleiermacher
Liquid biopsy & Catecholamine: Lieve Tytgat

October 23th


Update from the groups


Moderator: Roberto Luksch

Clinical Trial Committe: Juliet Gray
Biology: Gudrun Schleiermacher
Immunotherapy: Holger Lode,
NDD: Cormac Owens
Long term follow up: Vassilios Papadakis
Radiotherapy: Tom Boterberg

Molecular monitoring: Sue Burchill
Circulating biomakers: Lieve Tytgat
Bone marrow: Klaus Beiske
Pathology: Klaus Beiske
Surgery: Sabine Sarnacki
Radiology: Claudio Granata
Nuclear Medicine: Pending

Biobreak


General Assembly



Closure

Contact

Get in touch

Contact info

In compliance with the Organic Law on Protection of Personal Data 15/99 of 13 December, we let you know that your data shall be processed in the file responsibility of Grupo Geyseco SL, for purposes of promotion and other related with this congress. The completion of the application form imply permission to Grupo Geyseco SL to use personal data supplied for the purpose cited above. You can exercise your rights of access, modification and termination, email us to: datos@geyseco.es

Inqueries: +34 93 221 22 42

c/ Marina, 27 08005 BARCELONA

Sponsors

Sponsorship

To request information about the available sponsoring options,
please contact sponsors@geyseco.es and we will get in touch with you as soon as possible..